Cd3 antibody biolegend il6
Por um escritor misterioso
Descrição
Frontiers TriTECM: A tetrafunctional T-cell engaging antibody with built-in risk mitigation of cytokine release syndrome
Anti-IL-6 eluting immunomodulatory biomaterials prolong skin allograft survival
Frontiers IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function
Purified anti-human IL-17A Recombinant Antibody, IL-17A, QA18A46
TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity
Full article: Discovery and characterization of a monoclonal antibody targeting a conformational epitope of IL-6/IL-6Rα to inhibit IL-6/ IL-6Rα /gp130 hexameric signaling complex formation
Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogel
CD3 bispecific antibody–induced cytokine release is dispensable for cytotoxic T cell activity
Activation of Toll-like Receptor 2 (TLR2) induces Interleukin-6 trans-signaling
Frontiers A novel trivalent non-Fc anti-CD3 Collabody preferentially induces Th1 cell apoptosis in vitro and long-lasting remission in recent-onset diabetic NOD mice
de
por adulto (o preço varia de acordo com o tamanho do grupo)
